Skip to main content

. 1990 May 26;300(6736):1375–1376. doi: 10.1136/bmj.300.6736.1375

Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).

R A Schoenenberger ¹, W E Haefeli ¹, P Weiss ¹, R F Ritz ¹

PMCID: PMC1662960 PMID: 2372583

1375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Freedman R. A., Anderson K. P., Green L. S., Mason J. W. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol. 1987 Jan 1;59(1):168–169. doi: 10.1016/s0002-9149(87)80096-6. [DOI] [PubMed] [Google Scholar]
Guelon D., Bedock B., Chartier C., Haberer J. P. QT prolongation and recurrent "torsades de pointes" during erythromycin lactobionate infusion. Am J Cardiol. 1986 Sep 15;58(7):666–666. doi: 10.1016/0002-9149(86)90306-1. [DOI] [PubMed] [Google Scholar]
Kroboth P. D., Brown A., Lyon J. A., Kroboth F. J., Juhl R. P. Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects. Antimicrob Agents Chemother. 1982 Jan;21(1):135–140. doi: 10.1128/aac.21.1.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
McComb J. M., Campbell N. P., Cleland J. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cardiol. 1984 Oct 1;54(7):922–923. doi: 10.1016/s0002-9149(84)80237-4. [DOI] [PubMed] [Google Scholar]
Ponsonnaille J., Citron B., Richard A., Trolese J. F., Chaperon A., Barret B., Gras H. Etude électrophysiologique des effets pro-arythmogènes de l'érythromycine. Arch Mal Coeur Vaiss. 1988 Aug;81(8):1001–1008. [PubMed] [Google Scholar]

ACTIONS

RESOURCES